Company Filing History:
1 out of 96 
1 out of 124 
1 out of 319 
Years Active: 2014
Title: Chloé James: Innovator in Genetic Research
Introduction
Chloé James is a notable inventor based in Montrouge, France. He has made significant contributions to the field of genetic research, particularly in the study of myeloproliferative disorders. His work has implications for diagnosing and understanding various blood-related conditions.
Latest Patents
Chloé James holds a patent for the identification of a JAK2 mutation in polycythemia vera. The patent, which addresses the V617F variant of the protein-tyrosine kinase JAK2, is crucial for diagnosing erythrocytosis and thrombocytosis. This invention allows for the association of these conditions with myeloproliferative disorders and aids in the detection of the JAK2 V617F variant, facilitating the reclassification of these disorders into a new nosological group. He has 1 patent to his name.
Career Highlights
Throughout his career, Chloé has worked with prestigious institutions such as the Gustave Roussy Institute and the National Institute of Scientific Research. His research has been pivotal in advancing the understanding of genetic mutations and their implications for health.
Collaborations
Chloé has collaborated with esteemed colleagues, including William Vainchenker and Valérie Ugo. Their joint efforts have contributed to the advancement of knowledge in the field of myeloproliferative disorders.
Conclusion
Chloé James is a distinguished inventor whose work in genetic research has made a lasting impact. His innovative patent on the JAK2 mutation is a testament to his dedication to advancing medical science.